Trinity Biotech (TRIB) Enterprise Value (2009 - 2025)

Trinity Biotech has disclosed Enterprise Value across 17 years of filings, most recently posting -$5.1 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$5.1 million, up 3.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.1 million (up 3.66% YoY), and the FY2025 annual result was -$5.1 million, down 33.21% from the prior year.
• Enterprise Value came in at -$5.1 million for Q4 2025 at Trinity Biotech, down from -$1.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$152000.0 in Q1 2023 to a low of -$32.3 million in Q1 2021.
• The 5-year median for Enterprise Value is -$6.6 million (2022), against an average of -$12.5 million.
• Across the five-year window, Enterprise Value plunged 143.71% in 2021 and jumped 99.42% in 2023, its largest moves.
• Trinity Biotech's Enterprise Value stood at -$25.9 million in 2021, then surged by 74.12% to -$6.7 million in 2022, then surged by 42.31% to -$3.9 million in 2023, then plunged by 37.84% to -$5.3 million in 2024, then climbed by 3.66% to -$5.1 million in 2025.
• The last three Enterprise Value figures came in at -$5.1 million (Q4 2025), -$1.6 million (Q2 2025), and -$5.3 million (Q4 2024), per Business Quant data.